New eye drop for dry eye passes safety check in large trial
NCT ID NCT04735393
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested the safety of an eye drop called reproxalap in 757 adults with dry eye disease. Participants used the drops for up to 12 months, and researchers watched for serious side effects like vision changes or increased eye pressure. The goal was to see if the treatment is safe enough for long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
Conditions
Explore the condition pages connected to this study.